e-learning
resources
Stockholm 2002
Monday 16.09.2002
COPD - general -1
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Leptin and inflammatory cytokines during COPD exacerbation
P. Kythreotis, N. Lolis, E. Ablianitis, P. Bakakos, A. Kokkini, E. Anastasakou, A. Rasidakis (Athens, Greece)
Source:
Annual Congress 2002 - COPD - general -1
Session:
COPD - general -1
Session type:
Thematic Poster Session
Number:
1626
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Kythreotis, N. Lolis, E. Ablianitis, P. Bakakos, A. Kokkini, E. Anastasakou, A. Rasidakis (Athens, Greece). Leptin and inflammatory cytokines during COPD exacerbation. Eur Respir J 2002; 20: Suppl. 38, 1626
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Leptin during COPD exacerbation
Source: Eur Respir J 2003; 22: Suppl. 45, 435s
Year: 2003
Adiponectin as a biomarker of systemic inflammatory response in stable and exacerbation phases of COPD
Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation
Year: 2008
The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Dynamic of proinflammatory cytokines system and nonspecific markers of inflammation in patients with COPD before and after treatment with broncholitics
Source: Eur Respir J 2006; 28: Suppl. 50, 38s
Year: 2006
Neutrophil apoptosis and systemic inflammatory markers in acute exacerbation of COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 572s
Year: 2003
Procalcitonin and inflammatory cytokines in children with asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 115s
Year: 2002
Regulation of NF-kappaB-dependent cytokines during exacerbations of COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 824s
Year: 2006
IL-18 in infectious exacerbations of COPD
Source: Annual Congress 2011 - Biomarkers of allergic inflammation
Year: 2011
Infectious exacerbations of COPD: IL-18 and its relation to markers of inflammation
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010
The levels of proinflammatory cytokines in patients with dust-induced lung diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 536s
Year: 2001
Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011
Enhanced expression of proinflammatory cytokine (IL-18) and its receptor in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 551s
Year: 2006
Role of systemic inflammation mediated by IL-6 and TNF-alpha cytokines in chronic obstructive pulmonary disease and its progression: A three year follow up study
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Proinflammatory cytokines in induced sputum and COPD phenotype
Source: Annual Congress 2011 - COPD: human studies
Year: 2011
Rosuvastatin influence on inflammatory and anti-inflammatory cytokines in blood in patients with chronic obstructive pulmonary disease
Source: International Congress 2017 – COPD management
Year: 2017
Inflammatory cytokines of patients with peripheral arterial disease and COPD
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010
M2 chemokines during acute exacerbations of IPF
Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV
Year: 2012
Pathology, inflammation and cytokines of severe asthma
Source: Eur Respir Mon 2011; 51: 97-106
Year: 2011
Interleukin-33 and Th2 cytokines correlate in acute asthma
Source: International Congress 2016 – Clinical and molecular studies in asthma
Year: 2016
Investigation of alarmins, interleukin (IL-)23 and IL-36 sputum levels in chronic airway obstructive diseases.
Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept